Literature DB >> 32855278

Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype.

Antonio Vogelsberg1, Julia Steinhilber1, Barbara Mankel1, Birgit Federmann1, Janine Schmidt1, Ivonne A Montes-Mojarro1, Katrin Hüttl2, Maria Rodriguez-Pinilla3, Praveen Baskaran4, Sven Nahnsen4, Miguel A Piris3, German Ott2, Leticia Quintanilla-Martinez1, Irina Bonzheim1, Falko Fend5.   

Abstract

In situ follicular neoplasia (ISFN) is the earliest morphologically identifiable precursor of follicular lymphoma (FL). Although it is genetically less complex than FL and has low risk for progression, ISFN already harbors secondary genetic alterations, in addition to the defining t(14;18)(q32;q21) translocation. FL, in turn, frequently progresses to diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). By BCL2 staining of available reactive lymphoid tissue obtained at any time point in patients with aggressive B-cell lymphoma (BCL), we identified 10 paired cases of ISFN and DLBCL/HGBL, including 6 de novo tumors and 4 transformed from FL as intermediate step, and investigated their clonal evolution using microdissection and next generation sequencing. A clonal relationship between ISFN and aggressive BCL was established by immunoglobulin and/or BCL2 rearrangements and/or the demonstration of shared somatic mutations for all 10 cases. Targeted sequencing revealed CREBBP, KMT2D, EZH2, TNFRSF14 and BCL2 as the genes most frequently mutated already in ISFN. Based on the distribution of private and shared mutations, two patterns of clonal evolution were evident. In most cases, the aggressive lymphoma, ISFN and, when present, FL revealed divergent evolution from a common progenitor, whereas linear evolution with sequential accumulation of mutations was less frequent. In conclusion, we demonstrate for the first time that t(14;18)+ aggressive BCL can arise from ISFN without clinically evident FL as intermediate step and that during this progression, branched evolution is common.
Copyright © 2020, Ferrata Storti Foundation.

Entities:  

Keywords:  Aggressive B-cell lymphoma; Follicular lymphoma; Genetic evolution; In situ follicular neoplasia

Year:  2020        PMID: 32855278     DOI: 10.3324/haematol.2020.254854

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

1.  Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis.

Authors:  Xi Li; Yan Duan; Yuxia Hao
Journal:  BMC Med Genomics       Date:  2021-03-04       Impact factor: 3.063

2.  Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.

Authors:  Mathis Overkamp; Massimo Granai; Irina Bonzheim; Julia Steinhilber; Jens Schittenhelm; Wolfgang Bethge; Leticia Quintanilla-Martinez; Falko Fend; Birgit Federmann
Journal:  Virchows Arch       Date:  2020-12-15       Impact factor: 4.064

3.  A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab.

Authors:  Jiamao Lin; Xiaohui Wang; Chenyue Zhang; Shuai Bu; Chenglong Zhao; Haiyong Wang
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

Review 4.  Follicular lymphoma: updates for pathologists.

Authors:  Mahsa Khanlari; Jennifer R Chapman
Journal:  J Pathol Transl Med       Date:  2021-12-27

5.  Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.

Authors:  Rachel Dobson; Andrew Wotherspoon; Shizhang Alexander Liu; Francesco Cucco; Zi Chen; Yuan Tang; Ming-Qing Du
Journal:  J Pathol       Date:  2022-03-03       Impact factor: 9.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.